SG-based healthtech firm mClinica seeks to raise $20m amid virus outbreak

mClinica, a Singapore-headquartered healthtech startup that focuses primarily on the pharmacy industry, is looking to raise $20 million in its Series B round, just months after closing its bridge round with US-based Susquehanna International Group (SIG), a top company executive told DealStreetAsia.